KRX-0502 (Ferric Citrate) for the Treatment of IDA in Adult Subjects With NDD-CKD

Clinical trial NCT02268994 · COMPLETED

Trial details

NCT number: NCT02268994
Sponsor: Keryx Biopharmaceuticals
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Anemia of Chronic Kidney Disease

Start date: 2014-10-01
Primary completion: 2016-01-01
Enrollment: 234

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.